903556-96-7

Basic information

• Product Name: tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate
• Synonyms: tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate
• CAS NO: 903556-96-7
• Molecular Weight: 396.486
• Mol File: 903556-96-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate(903556-96-7)
• EPA Substance Registry System: tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate(903556-96-7)

Safety Data

• Hazardous Substances Data: 903556-96-7(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 501-53-1 benzyl chloroformate 
• 149355-52-2 7-cyano-1,2,3,4-tetrahydroisoquinoline 
• 1030019-28-3 C₁₈H₁₆N₂O₂ 
• 34619-03-9 tert-butyldicarbonate 

Relevant articles and documents

HETEROBICYCLIC METALLOPROTEASE INHIBITORS

The present invention relates generally to heterobicyclic containing pharmaceutical agents, and in particular, to heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic metalloprotease inhibiting compounds that exhibit an increased potency in relation to currently known metalloprotease inhibitors.

Substituted bis-amide metalloprotease inhibitors

This invention relates to substituted bis-amide pyrimidine compounds of Formula (I), which are useful for the treatment of metalloprotease mediated diseases, in particular MMP-13 related diseases.